SBC Medical Group Holdings Incorporated— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$40M
↓-10.9% -$5Mvs FY2024 (Q4)
Gross Profit
$29M
↓-14.6% -$5Mvs FY2024 (Q4)
Operating Income
$13M
↑+172.4% +$8Mvs FY2024 (Q4)
Net Income
$9M
↑+80.8% +$4Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $40M | $44M |
| COGS | $11M | $11M |
| Gross Profit | $29M | $34M |
| R&D | $0 | $0 |
| SG&A | $16M | $14M |
| D&A | $0 | $932K |
| Other OpEx | $0 | $14M |
| Operating Income | $13M | $5M |
| Interest Exp. | $53K | $12K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $13M | $5M |
| Tax | $4M | $0 |
| Net Income | $9M | $5M |
QuarterCharts · SEC EDGAR data · SBC · Comparing FY2025 (Q4) vs FY2024 (Q4)